AI will deliver transformative therapies at an exponential scale, addressing the complexities of biology that traditional ...

Explore the best investing ideas for 2025 at Investorideas.com. Get stock news, podcasts, videos, and insights on AI, crypto, ...

WASHINGTON (AP) — President Donald Trump on Monday signed into law the Take It Down Act, a measure that imposes penalties for ...

Pathos AI, a US biotech specializing in artificial intelligence for cancer drug development, has raised $365 million in a series D financing round, lifting its valuation to about $1.6 billion. The ...

Israeli artificial intelligence biotech startup SpotitEarly Ltd. today ... breath test for early cancer detection. The company uses AI and canines to analyze volatile organic compounds in exhaled ...

Pathos AI has secured $365 million in a series D raise as the artificial-intelligence-powered biotech looks to fund trials of solid tumor drugs sourced from Novo Nordisk and Prelude Therapeutics ...

On May 13, 2025, Viva Biotech successfully held the AIDD platform launch event "Enchantment of Drug Discovery," unveiling the advanced and comprehensive AI-Driven Drug Discovery (AIDD) platform to ...

SHANGHAI, May 15, 2025 /PRNewswire/ -- On May 13, 2025, Viva Biotech successfully held the AIDD platform launch event "Enchantment of Drug Discovery," unveiling the advanced and comprehensive AI ...

From early QSAR models to neural networks, and now to AlphaFold3, AI has progressively unlocked ... atomic-level 3D interaction predictions. Viva Biotech's approach to drug discovery is grounded ...

The development of Phenesafe AI will help us do all of these elements more quickly, and effectively.” PharmAla Biotech Holdings Inc. (CSE: MDMA)(OTCQB: MDXXF) is a biotechnology company focused on the ...